“Administration of the GluN2A‐ and GluN2B‐NMDA receptor antagonists, NVP‐AAM077 and ifenprodil , respectively, immediately following recall abrogated an established cocaine place preference, while preventing the activation of GSK3β in the amygdala, nucleus accumbens, and hippocampus during cocaine memory reactivation.”